# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-286828
Filing Date
2020-11-05
Accepted
2020-11-05 16:09:38
Documents
95
Period of Report
2020-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | d175316d10q.htm iXBRL | 10-Q | 4022533
2 | EX-10.2 | d175316dex102.htm | EX-10.2 | 39154
3 | EX-10.3 | d175316dex103.htm | EX-10.3 | 25033
4 | EX-31.1 | d175316dex311.htm | EX-31.1 | 10771
5 | EX-31.2 | d175316dex312.htm | EX-31.2 | 10756
6 | EX-32 | d175316dex32.htm | EX-32 | 4315
12 | GRAPHIC | g175316page12.jpg | GRAPHIC | 999
| Complete submission text file | 0001193125-20-286828.txt |  | 15620912

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA | teva-20200930.xsd | EX-101.SCH | 78924
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | teva-20200930_cal.xml | EX-101.CAL | 46628
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | teva-20200930_def.xml | EX-101.DEF | 533638
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | teva-20200930_lab.xml | EX-101.LAB | 546292
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | teva-20200930_pre.xml | EX-101.PRE | 571508
13 | EXTRACTED XBRL INSTANCE DOCUMENT | d175316d10q_htm.xml | XML | 3821714

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 201290503
SIC: 2834 Pharmaceutical Preparations